Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.)

Formulation, In-Vitro Characterization, And Antifungal Efficacy ‎of Itraconazole ‎Topical Niosomal Gel: Development and Microbiological Evaluation

Article info

2024-10-24
2024-12-13
2025-02-26
None - None

Keywords

  • Niosomal gel
  • Sustained release ‎action
  • Antifungal drugs
  • Itraconazole

Abstract

Background: Itraconazole is an effective antifungal agent; however, improving ‎its formulation as a topical agent is necessary due to its limited skin penetration ‎and duration of action. The present study aims to improve the efficacy of ‎antifungal treatments for skin infections by developing and studying itraconazole ‎‎(TCZ) in a prolonged-release niosomal gel (NSM-Gel) formulation. ‎Methods: TCZ‑loaded NSM-Gel was formulated using a thin film hydration ‎technique utilizing various non-ionic surfactants (tweens and spans). The TCZ ‎niosomal gels' different formulae were assessed for pH, entrapment efficiency ‎‎(EE%), particle size (PS), and polydispersity Index (PDI). Formula (TN4), which ‎was selected as the best formula, was further examined for zeta potential (ZP), ‎in-vitro ‎release, scanning electron microscopy (SEM), physical stability study, ‎and in-vitro antifungal efficacy. Results: the EE% for the developed NSM-Gel is satisfactory (86.41 – 98.44%), ‎PS between 4.12 and 8.17 µm, and PDI between 0.22 and 0.39. The release of ‎TCZ from the NSM-Gel provided an appropriate prolonged release effect. TN4 ‎had an elevated EE% with a delayed release profile (100.00% ± 1.25% after ‎‎18hrs). The results revealed the existence of vesicles characterized by a spherical ‎morphology. Physical stability studies of formula (TN4) showed good physical ‎characteristics. Furthermore, TN4 demonstrated superior antifungal activity ‎against Candida albicans, as evidenced by a larger inhibition zone than the ‎commercial product Venzole® gel 1% (2.40 vs. 1.50 cm). ‎ Conclusions: This investigation demonstrated the applicability of the NSM-Gel ‎in achieving the expected prolonged release effect for transdermal TCZ ‎administration in healing fungal infections.‎. (Style=ANU_Abstract)

Formulation, In-Vitro Characterization, And Antifungal Efficacy ‎of Itraconazole ‎Topical Niosomal Gel: Development and Microbiological Evaluation

معلومات المقال

2024-10-24
2024-12-13
2025-02-26
None - None

الكلمات الإفتتاحية

  • Niosomal gel
  • Sustained release ‎action
  • Antifungal drugs
  • Itraconazole

الملخص

Background: Itraconazole is an effective antifungal agent; however, improving ‎its formulation as a topical agent is necessary due to its limited skin penetration ‎and duration of action. The present study aims to improve the efficacy of ‎antifungal treatments for skin infections by developing and studying itraconazole ‎‎(TCZ) in a prolonged-release niosomal gel (NSM-Gel) formulation. ‎Methods: TCZ‑loaded NSM-Gel was formulated using a thin film hydration ‎technique utilizing various non-ionic surfactants (tweens and spans). The TCZ ‎niosomal gels' different formulae were assessed for pH, entrapment efficiency ‎‎(EE%), particle size (PS), and polydispersity Index (PDI). Formula (TN4), which ‎was selected as the best formula, was further examined for zeta potential (ZP), ‎in-vitro ‎release, scanning electron microscopy (SEM), physical stability study, ‎and in-vitro antifungal efficacy. Results: the EE% for the developed NSM-Gel is satisfactory (86.41 – 98.44%), ‎PS between 4.12 and 8.17 µm, and PDI between 0.22 and 0.39. The release of ‎TCZ from the NSM-Gel provided an appropriate prolonged release effect. TN4 ‎had an elevated EE% with a delayed release profile (100.00% ± 1.25% after ‎‎18hrs). The results revealed the existence of vesicles characterized by a spherical ‎morphology. Physical stability studies of formula (TN4) showed good physical ‎characteristics. Furthermore, TN4 demonstrated superior antifungal activity ‎against Candida albicans, as evidenced by a larger inhibition zone than the ‎commercial product Venzole® gel 1% (2.40 vs. 1.50 cm). ‎ Conclusions: This investigation demonstrated the applicability of the NSM-Gel ‎in achieving the expected prolonged release effect for transdermal TCZ ‎administration in healing fungal infections.‎. (Style=ANU_Abstract)

Since 2022

Cite Score (Scopus): 0.8
Time to First Decision: 3 Days
Submission to Acceptance: 45 Days
Acceptance Rate: 17%
Why should you
Publish With Us?
An-Najah National University
Nablus, Palestine
P.O. Box
7, 707
Fax
(970)(9)2345982
Tel.
(970)(9)2345560
(970)(9)2345113/5/6/7-Ext. 2628
E-mail
[email protected]
EIC
Prof. Waleed Sweileh

The Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) © 2024 by An-Najah University, Nablus, Palestine is licensed under CC BY-NC 4.0

News and Views